Profile
Corporate information
Official name
Genentech Incorporated
Registration country
Official name
Genentech Incorporated
Registration country
Investment activity status
Active investor
Company type
Discovery, development, commercialization and manufacturing of biotherapeutics by using human genetic informationFunding
Funding rounds
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Kleiner Perkins Caufield & Byers LLC | Venture capital firm. | United States |
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
|
Kleiner Perkins Caufield & Byers LLC | Venture capital firm. | United States |
Cap Table
Current and past shareholders
| Investor | Contacts | Round | |
|---|---|---|---|
|
|
Kleiner Perkins Caufield & Byers LLC Venture capital firm. |
+1 (650) 233-2750 |
N/A |
|
Roche Holding Ltd |
N/A |
Investments
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
23andMe Inc DNA testing and genome sequencing firm. |
United States | 22 May 2007 | Series A Initial investment. Round participant. Active |
|
|
|
Proacta Inc |
United States | 1 Jun 2004 | Series A |
|
|
|
InterMune Inc Biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases. |
United States | N/A |
||
|
|
Intradigm Corp |
United States | N/A |
||
|
|
Tolerx Inc Developer of a novel therapies focusing on modulating T-cell activities for treating autoimmune diseases, diabetes, and cancer. |
United States | N/A |
||
|
|
OncoMed Pharmaceuticals Inc Biotechnology company focused on scientific discoveries of cancer stem cells in solid tumors. |
N/A |
|||
|
|
CGI Pharmaceuticals Inc A biopharmaceutical company developing small molecule therapeutics for multiple oncology and immunology-based indications. |
United States | N/A |
||
|
|
Cellective Therapeutics Inc |
United States | N/A |
||
|
|
Bayhill Therapeutics A biopharmaceutical company focused on the translation of research into therapeutics for the treatment of autoimmune diseases. |
United States | N/A |
||
|
|
Kereos Inc Kereos, Inc. develops targeted molecular imaging agents and therapeutics designed to detect and treat cancer and cardiovascular disease. |
United States | N/A |
